tiprankstipranks
Omega Diagnostics Group PLC (GB:CNSL)
LSE:CNSL

Omega Diagnostics (CNSL) Financial Statements

2 Followers

Omega Diagnostics Financial Overview

Omega Diagnostics's market cap is currently ―. The company's EPS TTM is p-0.01; its P/E ratio is -4.04; Omega Diagnostics is scheduled to report earnings on August 5, 2024, and the estimated EPS forecast is p>-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Mar 22Sep 21Mar 21Sep 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 2.71M£ 1.60M£ 4.70M£ 5.83M£ 6.95M
Total Assets£ 17.13M£ 17.84M£ 28.90M£ 30.99M£ 28.45M
Total Debt£ 135.00K£ 370.00K£ 2.65M£ 2.84M£ 1.91M
Net Debt£ -2.58M£ -1.24M£ -2.05M£ -2.98M£ -5.05M
Total Liabilities£ 5.33M£ 6.02M£ 8.32M£ 7.32M£ 4.50M
Stockholders Equity£ 11.80M£ 11.82M£ 20.58M£ 23.67M£ 23.94M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

Omega Diagnostics Earnings and Revenue History

Omega Diagnostics Debt to Assets

Omega Diagnostics Cash Flow

Omega Diagnostics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis